Delivery Order SPE2DB22D2206-SPE2DB24FJB48

Award Date 7/7/24
Potential Completion Date 7/8/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,895.14 firm-fixed-price delivery order is for the supply of 4,565,597,451 units of the prescription drug Norvasc (amlodipine besylate) 5 mg tablets. The contract has an ultimate completion date of August 28, 2024 and does not utilize any set-aside designations. Amerisourcebergen is a major pharmaceutical distributor that...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Norvasc 10 mg tablets, a cardiovascular medication, valued at $1,086.46. The order has an ultimate completion date of August 2, 2024 and is a Firm Fixed Price contract type. This Delivery Order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides pharmaceutical products and medical supplies to the Department of Defense. The award, valued at $1,742.75, is a firm fixed price delivery order for Norvasc 5 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as...
This federal contract award is a delivery order (SPE2DB23FV5E7) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,396.63 firm fixed-price contract is for the delivery of NORVASC 2.5 MG TABLET 90S, a cardiovascular medication. The award has an ultimate completion date of February 15, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DB22D1041|SPE2DB24FTYR3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,121.11 firm-fixed-price delivery order is for the supply of NORVASC 5 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,093.44 firm-fixed-price contract is for the delivery of NORVASC 2.5 MG TABLET 90S, a cardiovascular medication. The contract is not set aside for any specific business type. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $2,244.76 firm fixed price delivery order is for the supply of NORVASC 10 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $83,150.57, is for the delivery of 90-count bottles of Norvasc 10 mg tablets, a medication used to treat high blood pressure and chest pain. The contract has a completion date of February 10, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $1,952.97, is a delivery order for the supply of Amlodipine-Valsartan 10-320 mg medication in 30-count packages. This award is not a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,849.84, is a delivery order for the supply of AMLODIPINE-VALSARTAN 5-320 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJB48
    Delivery Order

This federal contract award, worth $4,652.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Norvasc 5 mg tablets, a cardiovascular medication, with a completion date of July 8, 2024.

The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This delivery order award was not designated with any set-aside requirements, indicating open competition.

Generated 5/17/25, 9:50 AM